Germany Allows MS Patient to Grow Cannabis in Unprecedented Case
For the first time in Germany, a court has allowed a patient to cultivate their own cannabis for medicinal purposes. The 53-year-old man suffers from multiple sclerosis (MS).
Germany's Federal Institute for Drugs and Medical Devices (BfArM) confirmed on Sunday that the patient from Mannheim, southwestern Germany, will be allowed to grow a maximum of 130 cannabis plants a year in his bathroom. The cannabis is strictly for personal use, a spokesperson said.
BfArM had previously rejected requests to home-grow cannabis. There are currently more than 900 patients in Germany who are permitted to use the drug for medicinal purposes. However, the cannabis must be purchased from the pharmacy and financial costs covered by the patient. One gram currently costs around 15 euros ($16.85).
Prior to receiving his permit, the Mannheimer had filed multiple lawsuits, arguing that he could not afford the monthly costs of around 1,500 euros. In spring, Germany's Federal Administrative Court...
This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.
Follow us on Instagram
Connect with us on Linkedin